Detalles de la búsqueda
1.
Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants.
J Allergy Clin Immunol
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763170
2.
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time?
Ann Rheum Dis
; 83(1): 65-71, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37607810
3.
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis.
Ann Rheum Dis
; 82(4): 468-475, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526336
4.
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
J Autoimmun
; 135: 102984, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621174
5.
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
BMC Infect Dis
; 23(1): 332, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198536
6.
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
BMC Med
; 20(1): 100, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35236350
7.
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis.
Ann Rheum Dis
; 81(7): 937-943, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35470162
8.
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis
; 81(12): 1757-1766, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357161
9.
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis
; 82(6): 883-885, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720583
10.
Prospective study into COVID-19-like symptoms in patients with and without immune-mediated inflammatory diseases or immunomodulating drugs.
Ann Rheum Dis
; 80(10): 1364-1365, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849918
11.
Acute systemic reactions to sublingual immunotherapy for house dust mite.
Allergy
; 75(11): 2962-2963, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32449962
12.
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Lancet Rheumatol
; 4(5): e338-e350, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317410
13.
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Lancet Rheumatol
; 4(6): e417-e429, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527808
14.
Tapering of disease-modifying antirheumatic drugs: an overview for daily practice.
Lancet Rheumatol
; 3(9): e659-e670, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287612
Resultados
1 -
14
de 14
1
Próxima >
>>